|
|
|
||||||||||
facilities
This project aims at investigation of the neurobiological basis of different psychiatric disorders and related treatment response. To that clinical symptoms are correlated with metabolic and functional measures obtained in vivo by MRS, functional and structural MRI in humans and animal models.
Metabolites of particular interest are neurotransmitters and their precursors such as glutamine (Gln), glutamate (Glu), and gamma amino butyric acid (GABA), as well as antioxidants such as glutathion (GSH) and ascorbic acid (Asc), whose important roles in the pathophysiology of psychiatric disorders like major depression, schizophrenia, panic disorders or obsessive compulsive disorder are not understood.
In humans these metabolites are currently assessed by JPRESS spectroscopy and 2D prior-knowledge fitting (ProFit) at 3T. In future ultra-high field MRS and MRSI, absolute quantification based on the ERETIC reference standard as well as 13C and 31P MRS might be applied to physiological studies in the context of psychiatric disorders.
Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne
graphische Elemente dargestellt. Die Funktionalität der
Website ist aber trotzdem gewährleistet. Wenn Sie diese
Website regelmässig benutzen, empfehlen wir Ihnen, auf
Ihrem Computer einen aktuellen Browser zu installieren. Weitere
Informationen finden Sie auf
folgender
Seite.
Important Note:
The content in this site is accessible to any browser or
Internet device, however, some graphics will display correctly
only in the newer versions of Netscape. To get the most out of
our site we suggest you upgrade to a newer browser.
More
information